Skip to main content
Log in

Health and economic burden of poor quality antimalarials

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Notes

  1. 2017 US dollars

  2. Nigerian National Agency for Food and Drug Administration and Control

Reference

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Health and economic burden of poor quality antimalarials. PharmacoEcon Outcomes News 835, 16 (2019). https://doi.org/10.1007/s40274-019-6153-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-019-6153-6

Navigation